In a random survival forest model, variants in the GRIN2C gene encoding the GluN2C subunit of NMDA receptor were part of a group of 7 variant genes found to predict shorter event-free survival in high-risk pediatric patients with B-ALL (145). This evidence concerns the gene GRIN2C and acute lymphoblastic leukemia.